AKT3 and diabetic kidney disease: CIRC-AKT3 inhibits the proliferation of glomerular Mesangial cells and the production of Mesangial matrix in patients with diabetic nephropathy by regulating miR-296-3phammer E-cadherin signal, thus delaying the development of diabetic nephropathy 45.